Assoc Prof Dr. Chen Wang | Anti-tumor Nanomaterials | Best Researcher Award

Posted on by Pencis

Assoc Prof Dr. Chen Wang | Anti-tumor Nanomaterials | Best Researcher Award

Guangxi Medical University Cancer Hospital | China

Author Profile

Scopus

Orcid id

🌟 Distinguished Scientist Award: Dr. Chen Wang 🌟

Full Name: Chen Wang
Gender: Male
Designation: Associate Research Fellow
Department: Guangxi Key Laboratory of Basic and Translational Research for Colorectal Cancer
Institution/Organization: Guangxi Medical University Cancer Hospital
Qualification: Ph.D.
Area of Specialization: Oncology Therapeutics and Novel Approaches
Sub Division: Anti-tumor Nanomaterials

📚 Education and Experience

Born in Liaoning, China, in 1988, Dr. Chen Wang has dedicated his career to advancing cancer treatment through innovative research in materials science and engineering. He earned his BS (2010) and MS (2013) degrees from Shenyang University of Technology, followed by a Ph.D. from Harbin Engineering University in 2019. Dr. Wang’s postdoctoral research took place at the Changchun Institute of Applied Chemistry and Southern Medical University. He began his academic career at Jilin University of Chemical Technology and joined Guangxi Medical University Cancer Hospital in 2020, becoming an associate research fellow in 2022.

🧬 Research and Innovations

Dr. Wang specializes in the synthesis and clinical application of novel anti-tumor nanomaterials. His pioneering work on calcium overload as a novel treatment for tumor cells has garnered significant attention. The development of GMCP (GOx@MMPB@CaP-PEG) nanoparticles showcases his innovative approach, combining enhanced intratumor reactive oxygen species (ROS) levels with photothermal therapy to promote apoptosis in tumor cells.

🏆 Achievements

  • Publications: Nearly 30 SCI-indexed original articles, including 11 as first/corresponding author.
  • Projects: Completed 12 research projects, with 5 as the principal investigator.
  • Patents: Holds 7 patents.
  • Editorial Roles: Serves on the editorial boards and as a reviewer for multiple journals.
  • Memberships: Member of the China Food and Drug Enterprise Quality and Safety Promotion Association.
  • Citations: 495 citations in Scopus/Web of Science.
  • H-index: 13.
  • Impact Factor: Cumulative impact factor of 141.8 over the last three years.

Dr. Wang’s work in oncology therapeutics, particularly in anti-tumor nanomaterials, positions him as a leading figure in his field, making him a deserving recipient of the Distinguished Scientist Award.

🌐 Professional Links

📄 Certifications

  • Education Proof (Ph.D.): 1021722019110003
  • Government ID (Passport): E36369406

Dr. Chen Wang’s dedication to research, innovation, and the application of novel cancer treatments underscores his significant contributions to the field of oncology therapeutics.

 

📊🔬Notable Publication:

 

 

 

 

Dr. Lei Xia | Theranostics | Best Researcher Award

Posted on by Pencis

Dr. Lei Xia | Theranostics | Best Researcher Award

Peking University Cancer Hospital |  China

Author Profile

Scopus

Orcid Id

Dr. Xia Lei, PhD 🧬

Affiliation:
Department of Nuclear Medicine, Peking University Cancer Hospital
Physician, Associate Researcher

Contact Information:
📞 Phone: 18811177191
✉ Email: xialei9012288@126.com

Biography:

Dr. Xia Lei, PhD, currently serves as a physician and associate researcher in the Department of Nuclear Medicine at Peking University Cancer Hospital. Dr. Lei graduated from the Medical School of Peking University in 2020. His expertise and research interests lie in the innovative field of nuclear medicine, particularly focusing on the development and clinical application of radiopharmaceutical probes for tumor targeting.

His primary research areas include:

  1. Construction of Tumor-Targeted Multimodal Imaging Molecular Probes đŸ©»
    • Dr. Lei is dedicated to creating advanced imaging probes that can target tumors with high precision, enhancing the accuracy of tumor detection and diagnosis.
  2. Development and Preliminary Application of Novel Integrated Diagnostic and Therapeutic Probes đŸ§«
    • He is pioneering the integration of diagnostic and therapeutic functions into single probes, aiming to streamline and improve the effectiveness of cancer treatment.
  3. Preparation and Clinical Translation of Tumor-Targeted Radiopharmaceutical Probes đŸ§Ș
    • Dr. Lei’s work involves preparing radiopharmaceuticals that specifically target tumors and translating these innovations from the lab to clinical settings to benefit patients.

Principal Investigator in Projects:

Dr. Lei has been the principal investigator for several prestigious projects, showcasing his leadership in research and innovation:

  1. National Natural Science Foundation of China, Young Scientists Fund (NO.82202201) 🌟
    • RMB 300,000 (January 2023 – December 2025)
  2. Young Talents Support Plan by the China Association for Science and Technology (NO. YESS20220230) 🌟
    • RMB 600,000 (January 2023 – December 2025)
  3. Beijing Natural Science Foundation, General Program (NO.7242266) 🌟
    • RMB 200,000 (January 2024 – December 2026)
  4. Peking University Cancer Hospital Science Innovation and Translation Fund 🌟
    • RMB 140,000 (January 2024 – December 2024)
  5. Medical School of Peking University, Young Scientists Innovation Fund 🌟
    • RMB 40,000
  6. Internal Fund of Peking University Cancer Hospital 🌟
    • RMB 80,000
  7. Peking University Cancer Hospital Science Innovation Nurturing Fund 🌟
    • RMB 100,000

Dr. Lei’s contributions to the field of nuclear medicine are instrumental in advancing the understanding and treatment of cancer, reflecting his commitment to medical innovation and patient care.

 

📊🔬Notable Publication:

 

 

 

 

Assoc Prof Dr. Urszula Bazylinska | Drug Delivery System | Best Researcher Award

Posted on by Pencis

Assoc Prof Dr. Urszula Bazylinska | Drug Delivery System | Best Researcher Award

Wroclaw University of Science and Technology |  Poland

Author Profile

Scopus

Orcid Id

🌟Urszula Jolanta BazyliƄska, Ph.D. Eng., D.Sc

🔬 Associate Professor

đŸ›ïž Department of Physical and Quantum Chemistry

🎓 Faculty of Chemistry, Wroclaw University of Science and Technology

📍 Wybrzeze Wyspianskiego 27, 50-370 Wroclaw, Poland

📧 E-mail: urszula.bazylinska@pwr.edu.pl

Urszula Jolanta BazyliƄska holds a Ph.D. in chemical sciences and a D.Sc. in chemical sciences from the Faculty of Chemistry at Wroclaw University of Science and Technology, Poland. Her research expertise centers around dispersed systems, focusing on surfactant self-organization, structural design, and physicochemistry of colloidal dispersions. She specializes in nanoemulsions, microemulsions, multiple emulsions, specialty liposomes, and lyotropic liquid crystalline nanoparticles like cubosomes and hexosomes.

Her work is dedicated to applications in pharmaceutical and medical fields, particularly in anticancer treatments and diagnostics (theranostic applications), emphasizing targeting efficiency and prolonged circulation in the bloodstream.

📚Diplomas/Degrees:

  • 2019: D.Sc. in chemical sciences
  • 2013: Ph.D. in chemical sciences
  • 2008: M.Sc. Eng. in biotechnology

🔬Professional Experience:

  • Scientific internships in various prestigious institutions including ETH ZĂŒrich, University Milano-Bicocca, and Northwestern University, among others.

🏅Awards and Distinctions:

  • Guest Editor of a special issue of Processes (MDPI): Nanoemulsion Processes Design and Applications (2020)
  • Member of Pharmaceutics (MDPI) Reviewer Board (2019)
  • European Colloid and Interface Society (ECIS) Award for outstanding scientific achievements (2016)
  • Ministry of Science and Higher Education Fellowship for outstanding young scientists (2015)
  • Rector of Wroclaw University of Science and Technology Award for PhD thesis (2014)
  • Foundation for Polish Science Fellowship – START Program (2013)
  • Association for the Support of Cancer Research Award (2013)
  • Ministry of Science and Higher Education Award for great scientific achievements (2012)
  • Rector of Wroclaw University of Science and Technology Award for outstanding PhD students (2012)
  • “Hot article” distinction from Soft Matter RCS Publishing (2011)
  • National Science Foundation Award for best presentation (2010)

Dr. BazyliƄska’s contributions to the field of nanostructured formulations and drug delivery systems underscore her commitment to advancing medical science through innovative research and application.

This biography summarizes Urszula Jolanta BazyliƄska’s academic achievements, research focus, professional experience, and accolades, highlighting her significant contributions to the field of physical and quantum chemistry.

 

📊🔬Notable Publication: